A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema

NCT03622593 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

951

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Aflibercept
DRUG: Faricimab
PROCEDURE: Sham Procedure

Sponsor

Hoffmann-La Roche